1.Diabetic polyneuropathy: mechanisms, prevention and treatment, are we doing too little, too late?
Philippine Journal of Anesthesiology 2001;13(1):45-54
Diabetic polyneuropathy affects millions of people with diabetes. Although, the symptoms may be highly unpleasant, management have concentrated mainly on the disease process and other more visible or devastating secondary complications like diabetic ulcers and cardiac arrhythmia. Glycemic control remains the most important aspect in the management of diabetes that can deter or decelerate subsequent development of diabetic polyneuropathy. However, concentration on this aspect alone veers away from control of symptoms that may improve quality of life of patients.
NEUROPATHY
;
CARDIAC ARRHYTHMIA
;
PAIN
;
INJURY
;
NERVE
3.Clinical Electrophysiological Studies on the Chronic Recurrent Sustained Ventricular Tachycardia.
Korean Circulation Journal 1984;14(2):243-251
Clinical electrophysiological studies(EPS) were done in seven patients with chronic recurrent sustained ventricular tachycardia(VT) in an attempt to delineate the reproducibility and to select the effective antiarrhythmic drugs for the prevention of the recurrence of VT. We could induce and terminate the sustained VT, and could select the effective antiarrhythmic drugs in all patient in the cardiac catheterization laboratory with EPS. With these effective antiarrhythmic drugs VT did not recur for the follow up period of 15 to 20 months. In view of the serious nature of the VT and the demonstrated benefits of EPS, we could conclude that patients with chronic recurrent sustained VT should undergo EPS.
Anti-Arrhythmia Agents
;
Cardiac Catheterization
;
Cardiac Catheters
;
Follow-Up Studies
;
Humans
;
Recurrence
;
Tachycardia, Ventricular*
4.Amiodarone-Induced ARDS after MVR: A case report.
Gi Bok LEE ; Eung Joong KIM ; Hyun Keun CHEE ; Yoon Cheol SHIN
The Korean Journal of Thoracic and Cardiovascular Surgery 2002;35(8):594-598
Amiodarone is an iodinated benzofuran derivative that has been proved effective in the control of supraventricular and ventricular arrhythmias refractory to other antiarrhythmic drugs. In patients treated with amiodarone, subsequent surgical intervention is a common clinical scenario, but unfortunately we do not have definite data about complications due to amiodarone after cardiac surgery. Some reports have shown that amiodarone treatment can be associated with a state of alpha-adrenergic and beta-adrenergic receptor blockade, which requires more pacing and epinephrine infusion for perioperative hemodynamic support. And some reports have also identified a severe form of ARDS in patients on amiodarone therapy which was associated with siginificant morbidity and mortality. We exprienced a patient who expired after mitral valve replacement due to amiodarone-induced ARDS; therefore, we report this case with a brief literature.
Amiodarone
;
Anti-Arrhythmia Agents
;
Arrhythmias, Cardiac
;
Epinephrine
;
Hemodynamics
;
Humans
;
Mitral Valve
;
Mortality
;
Thoracic Surgery
7.Ventricular Arrhythmia during Tracheal Intubation and Extubation under General Anesthesia Possibly Induced by Amisulpride: A Case Report.
Clinical Psychopharmacology and Neuroscience 2018;16(3):358-360
We are presenting the first documented case of amisulpride related ventricular arrhythmia during tracheal intubation and extubation under general anesthesia in an 48 year-old female with psychiatric history of chronic schizophrenia who was treated with amisulpride. This case suggests the threshold of perioperative arrhythmia is possibly decreased in patients with long-term antipsychotic medication. So, the potential risk of antipsychotics-induced perioperative arrhythmia should be evaluated, as well as heart rhythm monitoring, prophylactic use of antiarrhythmic drugs, and preoperative adjustment of antipsychotics should be considered.
Anesthesia, General*
;
Anti-Arrhythmia Agents
;
Antipsychotic Agents
;
Arrhythmias, Cardiac*
;
Female
;
Heart
;
Humans
;
Intubation*
;
Schizophrenia
9.Emergency cesarean delivery in a parturient who had an intractable paroxysmal supraventricular tachycardia: A case report.
Kyoung Ok KIM ; Eun Jung CHANG ; Jin HAN ; Hun CHO
Korean Journal of Anesthesiology 2012;63(4):360-362
Paroxysmal supraventricular tachycardia (SVT) is a common arrhythmia in the parturient and can occur with or without an underlying organic heart disease. A woman of 35 weeks' gestation, who had a paroxysmal SVT that was resistant to antiarrhythmic drugs and electric cardioversion, required emergency Cesarean delivery. The Cesarean delivery was performed under spinal anesthesia and a healthy baby was delivered uneventfully. SVT spontaneously converted to normal sinus rhythm right after delivery of the baby.
Anesthesia, Spinal
;
Anti-Arrhythmia Agents
;
Arrhythmias, Cardiac
;
Cesarean Section
;
Electric Countershock
;
Emergencies
;
Female
;
Heart Diseases
;
Humans
;
Pregnancy
;
Tachycardia, Supraventricular
10.Nonpharmacologic Treatment for Atrial Fibrillation.
Korean Journal of Medicine 2011;81(4):428-433
Atrial fibrillation (AF) is the most common cardiac arrhythmia and its prevalence is expected to increase with increasing age. The risk of stroke also increases substantially with age. There are three strategies for the management of AF, that is, rate control, rhythm control and anticoagulation for prevention of embolism. Antiarrhythmic drugs are usually used for rhythm control as first line therapy but there are some limitations in using antiarrhythmic drugs for AF. Catheter ablation of AF should be considered as second line therapy. The primary indication for catheter ablation is the presence of symptomatic AF refractory or intolerant to antiarrhythmic medication. Warfarin is more effective effective in preventing stroke than aspirin and combination aspirin-clopidogrel. Despite its proven efficacy, warfarin is often not well tolerated by patients, has a very narrow therapeutic range, and has a high risk for bleeding complications. Echocardiography and autopsy studies showed that the left atrial appendage (LAA) was the source of thrombi in more than 90% of patients with non-valvular AF. Percutaneous catheter-based devices have been developed to close and thereby effectively exclude the LAA from the systemic circulation.
Anti-Arrhythmia Agents
;
Arrhythmias, Cardiac
;
Aspirin
;
Atrial Appendage
;
Atrial Fibrillation
;
Autopsy
;
Catheter Ablation
;
Echocardiography
;
Embolism
;
Hemorrhage
;
Humans
;
Prevalence
;
Stroke
;
Warfarin